AI assistant
Sending…
LIGAND PHARMACEUTICALS INC — Director's Dealing 2014
Mar 20, 2014
31289_dirs_2014-03-20_250cd96f-e7bc-4366-a40f-e47bf463cbdd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2014-03-18
Reporting Person: Davis Todd C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-18 | Common Stock | S | 2500.0 | $79.4549 | Disposed | 37536 | Direct |
| 2014-03-19 | Common Stock | S | 5000.0 | $79.6294 | Disposed | 32536 | Direct |
More from LIGAND PHARMACEUTICALS INC
Proxy Solicitation & Information Statement
2026
May 18
M&A Activity
2026
May 18
Interim / Quarterly Report
2026
May 8
Earnings Release
2026
May 7
Major Shareholding Notification
2026
May 1
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 27
M&A Activity
2026
Apr 27
Annual Report
2026
Apr 21